Innovations in Automation—High-Throughput Dynamic Light Scattering for Screening Biotherapeutic Formulations

Published on: 
BioPharm International, BioPharm International-10-15-2015, Volume 2015 eBook, Issue 2

This article introduces the technology that powers automated HT–DLS and explores its practical applications in enhancing formulation stability investigations.

BioPharm International

eBooks Volume 28, Issue 14  

Assessing a drug candidate’s suitability during preformulation is essential to minimize the risk of costly downstream failure. Stability is a defining feature of biotherapeutic performance; measuring formulation stability during early-phase screening allows developers to make robust predictions of suitability for further development.    Read this article and other articles in


BioPharm International

's 2015